China Medicine Corporation
CHME · OTC
12/31/2009 | 12/31/2008 | 12/31/2007 | 12/31/2006 | |
|---|---|---|---|---|
| Market Cap | $65,650 | $10,925 | $35,187 | $21,762 |
| - Cash | $472 | $2,792 | $5,768 | $371 |
| + Debt | $9,506 | $0 | $0 | $0 |
| Enterprise Value | $74,685 | $8,133 | $29,419 | $21,391 |
| Revenue | $64,751 | $53,648 | $42,105 | $23,992 |
| % Growth | 20.7% | 27.4% | 75.5% | – |
| Gross Profit | $18,984 | $15,573 | $12,397 | $8,975 |
| % Margin | 29.3% | 29% | 29.4% | 37.4% |
| EBITDA | $13,278 | $11,349 | $9,199 | $6,346 |
| % Margin | 20.5% | 21.2% | 21.8% | 26.5% |
| Net Income | $1,718 | $9,126 | $6,875 | $4,788 |
| % Margin | 2.7% | 17% | 16.3% | 20% |
| EPS Diluted | 0.11 | 0.6 | 0.5 | 0.63 |
| % Growth | -81.7% | 20% | -20.6% | – |
| Operating Cash Flow | $16,959 | $4,209 | -$2,310 | -$2,218 |
| Capital Expenditures | -$3,674 | -$2,666 | -$390 | -$826 |
| Free Cash Flow | $13,286 | $1,543 | -$2,700 | -$3,045 |